Home » Topics » Regulatory

Regulatory
RSS

Mianserin studied for treatment of sexual dysfunction

July 16, 1997

Bigmar submits ANDA for leucovorin

July 15, 1997

Teva receives FDA approval for generic estazolam

July 15, 1997

FDA approves antibacterial generic from Mylan

July 14, 1997

Mylan antianxiety/antipsychotic generic approved by FDA

July 14, 1997

Profile of a new formulation of eperisone hydrochloride

July 14, 1997

Knoll receives FDA approval to market Mavik for new indication

July 14, 1997

Ergo Science's Ergoset enters phase II/III trials in obesity

July 14, 1997

Mylan, Purepac and ESI Lederle report FDA generic approvals

July 14, 1997

Once-daily extended-release venlafaxine evaluated in depression

July 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...